ARVC 5-Year Arrhythmic Risk Estimator
Use this educational calculator to estimate relative 5-year risk of serious ventricular arrhythmia in people with suspected or diagnosed arrhythmogenic right ventricular cardiomyopathy (ARVC).
What is ARVC?
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart muscle disorder where normal myocardium can be replaced by fibrous and fatty tissue, especially in the right ventricle. This structural change can increase the risk of ventricular arrhythmias, fainting episodes, and in some cases sudden cardiac death. ARVC can also involve the left ventricle in many patients, particularly in later or more diffuse forms.
Diagnosis often combines several data points: ECG findings, rhythm monitoring, cardiac imaging, family history, genetic testing, and clinical symptoms. Because ARVC can look different from person to person, risk assessment is usually individualized.
How this arvc risk calculator works
This tool uses a point-based model built from commonly recognized clinical risk markers. It estimates a broad 5-year arrhythmic risk category and gives practical follow-up guidance. The calculator is intended for education and discussion preparation, not for stand-alone treatment decisions.
Inputs included in this model
- Clinical events: prior sustained VT/VF, recent unexplained syncope, and non-sustained VT.
- Arrhythmia burden: PVC percentage from ambulatory rhythm monitoring.
- Ventricular function: right and left ventricular ejection fraction.
- Substrate markers: MRI scar (late gadolinium enhancement), ECG repolarization abnormalities.
- Inherited risk: pathogenic mutation and family history of early sudden death.
How to interpret your result
Low risk
A lower score suggests a smaller short-term risk of major ventricular arrhythmia, but not zero risk. Ongoing surveillance remains important because ARVC can progress over time.
Intermediate risk
Intermediate scores usually justify closer rhythm surveillance, repeat imaging, and a focused discussion about lifestyle choices, especially exercise intensity and frequency.
High and very high risk
Higher scores indicate more concerning features and should trigger prompt specialist evaluation. Depending on complete clinical context, your care team may discuss antiarrhythmic therapy, catheter ablation strategy, or ICD candidacy for primary or secondary prevention.
Key risk factors explained
Prior sustained VT/VF
This is one of the strongest predictors of recurrent malignant arrhythmia. In most frameworks, this finding alone places a patient in a high-priority follow-up category.
Unexplained syncope
Syncope can be benign, but in ARVC it may reflect transient ventricular tachyarrhythmia. The context matters: exertion-related, sudden, and unexplained events are more concerning.
Reduced RVEF/LVEF
Declining ventricular function can signal broader disease substrate and elevated electrical instability risk. Biventricular involvement generally warrants tighter surveillance and longitudinal reassessment.
Clinical use: best practices
- Use this estimate as a conversation starter, not a final answer.
- Review values against your most recent ECG, Holter, MRI, and echo reports.
- Track trends over time; single snapshots can miss disease progression.
- Ask about family cascade screening if ARVC is suspected or confirmed.
- Discuss individualized exercise guidance with a cardiology specialist.
Limitations
No online calculator can reproduce specialist multidisciplinary judgment. Real-world care includes genotype-phenotype details, burden and morphology of arrhythmia, medication response, exercise exposure history, inflammatory activity, and procedural history. If you have chest pain, syncope, palpitations with dizziness, or any emergency symptom, seek urgent medical care immediately.
Bottom line
An ARVC risk calculator is useful for organizing information and understanding relative risk direction. It is most valuable when paired with expert interpretation. If your result is intermediate or higher, bring it to your cardiology appointment and ask for a formal risk review tailored to your full clinical profile.